Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Pulmonary Diseases
NCT05147688
Asthma, Bronchial Diseases
St John's, Antigua and Barbuda
View Trial DetailsNCT Number: NCT00851695
Asthma and chronic obstructive pulmonary disease (COPD) are diseases that affect a person's ability to breathe normally. People who do not receive enough vitamin D may have a higher risk of developing asthma or COPD. This study will examine previously collected blood samples of participants in three studies to determine whether people with low vitamin D levels have an increased risk of severe asthma or COPD.
Looking for future studies?
Notify Me5 year–80 year
All sexes
Observational
Asthma and COPD are among the leading causes of illness in children and adults, respectively. Asthma is the most common long-term disease among children in the developed world, and approximately 16 million people in the United States have COPD, which is now the fourth most common cause of death in this country. Vitamin D, both a nutrient and a hormone, can be taken in through diet and exposure to sunlight. Many children and adults have a vitamin D deficiency and there is concern that current recommended intake levels may be inadequate. A vitamin D deficiency can cause immune system dysfunction and may increase the risk of developing immune-mediated disorders, such as multiple sclerosis, inflammatory bowel disease, rheumatoid arthritis, and various cancers. Because of its role in immune development and function, a vitamin D deficiency may also be related to the development of severe asthma in children and to greater lung function decline in adults, leading to COPD. Preliminary research shows that people with asthma who take vitamin D have an enhanced response to corticosteroids, a common medication used to treat asthma. This finding suggests that vitamin D could possibly be used to improve asthma treatment. The purpose of this study is to measure vitamin D levels in participants of three previous studies and determine whether lower vitamin D levels are related to the development of severe asthma or COPD.
This study will examine previously collected blood samples from participants in three studies. There will be no study visits specifically for this study. The three studies include the following:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Time frame: Measured at Year 4 in the original study
Time frame: Measured at Year 15 in the original study
Time frame: Measured at Year 4 in the original study
Brigham and Women's Hospital
Other
Vitamin D in Obstructive Lung Diseases
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05147688
Asthma, Bronchial Diseases
St John's, Antigua and Barbuda
View Trial DetailsNCT06469112
Asthma, Bronchial Diseases
Bursa, Turkey (Türkiye)
View Trial DetailsNCT05685381
Asthma, Bronchial Diseases
Beacon, New York, United States
View Trial DetailsNCT02760329
Asthma, Bronchial Diseases
Loma Linda, California, United States
View Trial Details